This program equips you with practical knowledge and evidence-based practices to optimize patient care in respiratory care. Interested participants must apply to be considered for enrollment. All applications will be carefully reviewed. Priority will be given to applicants from the developing world who may not otherwise have access to this type of training opportunity. All applicants will be notified of their acceptance status upon review.
Dr Jim Fink International Aerosol Medicine Training Program Developed By Dr Arzu Ari
This educational course has been made possible through an unrestricted educational grant provided by Aerogen.
Course Cost
This course is FREE. The student enrollment limit is 40.
Duration
Complete this virtual course in 7 days.
Start Date
June 1st, 2025 - June 8th, 2025
Materials
No textbooks required.
About the Course
Dr. Jim Fink’s International Aerosol Medicine Training Program developed by Dr. Arzu Ari on is a comprehensive initiative aimed at advancing global expertise in the science and application of aerosol therapies. This program brings together healthcare professionals, researchers, and industry leaders to explore the latest innovations in aerosol delivery systems, inhalation therapies, and respiratory care. Participants will gain in-depth knowledge on the Fundamentals of Aerosol Drug Delivery Aerosol Delivery Devices Aerosol Drug Delivery to Spontaneously Breathing Patients in Acute Care Aerosol Drug Delivery in Critical Pulmonary Care, and Aerosol Drug Delivery to Children. Through expert-led sessions, participants will develop the skills needed to optimize aerosol therapies across diverse patient populations and clinical settings.
Investment in Your Professional Growth
Apply for the International Aerosol Medicine Training Program to advance your skills in aerosol drug delivery and respiratory care. Gain practical, evidence-based knowledge from leading experts in the field.
Participants Will Gain In-Depth Knowledge
- Fundamentals of Aerosol Drug Delivery
- Aerosol Delivery Devices
- Aerosol Drug Delivery to Spontaneously Breathing Patients in Acute Care
- Aerosol Drug Delivery in Critical Pulmonary Care
- Aerosol Drug Delivery to Children
Program Benefits
- Through expert-led sessions, participants will gain the knowledge necessary to optimize aerosol therapies for diverse patient populations and clinical settings.
More About Jim Fink
This innovative and comprehensive online training program will be dedicated to the legacy and teaching of Dr. Jim Fink, a renowned scholar and towering figure in aerosol research. Dr. Fink has made profound and lasting impacts through groundbreaking research, seminal publications, and transformative ideas. His pioneering work has not only advanced the frontiers of knowledge but has also shaped the discourse and practice within aerosol medicine influencing scholars, policymakers, and practitioners worldwide. Therefore, the program is designed to honor the invaluable contributions and intellectual prowess of Dr. Jim Fink, while inspiring and equipping the next generation of clinicians and scholars in aerosol medicine. Through a blend of lectures, discussions, and assignments, participants will have the opportunity to delve deeply into the key concepts and principles of safe and effective aerosol drug delivery championed by Dr. Fink.
Program Schedule: Summer 2025
Key Dates for Application, Registration, and Course Participation
| Event | Dates |
|---|---|
| Application Timeline | April 14, 2025 – April 21, 2025 |
| Registration Period | May 5, 2025 – May 16, 2025 |
| Course Dates | June 1st, 2025 - June 8th, 2025 |
Meet your Instructor
Dr. Arzu Ari holds a Ph.D. in Educational Policy, focusing on Higher Education Administration from Georgia State University (GSU). Her background is diverse, with undergraduate degrees in Physical Therapy and Respiratory Care and master's degrees in Public Health and Allied Health. Her scholarship merited tenure at both GSU and Texas State University (TXST).
In 2024, Dr. Ari received the Forest Bird Lifetime Scientific Achievement Award from the American Respiratory Care Foundation (ARCF) and the Mariel Muir Award for Excellence in Faculty Mentoring from TXST. In 2023, she was honored with the Regent’s Professor Award from the Texas State University System Board of Regents. Recognized for her significant contributions to research, teaching, and service in Pulmonary Medicine and Respiratory Care, she is a Fellow of both the American College of Chest Physicians (FCCP) and the American Association for Respiratory Care (FAARC).
Currently, Dr. Ari serves as a Regent’s Professor and Associate Dean for Research at TXST. She also directs the International Education Recognition System.
Since joining academia in 2001, Dr. Ari has published 93 peer-reviewed articles, 85 conference proceedings, 17 book chapters, 2 clinical practice guidelines, and 2 books. She has delivered 342 presentations at 145 conferences worldwide and has received 36 awards and 16 grants, securing at least one grant every year for the past 14 years.
Her primary research focus is Aerosol Medicine, leading to four key developments with a global impact on aerosol drug delivery for patients with pulmonary diseases:
1. Helping clinicians understand current practices of aerosol drug therapy.
2. Identifying best practices for aerosol drug delivery, not only in spontaneously breathing patients but also in critical care settings.
3. Evaluating the performance of aerosol delivery devices to optimize inhaled drug delivery in patients with respiratory disorders.
4. Generating new concepts and methods that enhance aerosol drug delivery to adults, pediatrics, infants, and newborns.
With 25 years of experience in basic, translational, and clinical research, Dr. Ari has successfully brought together experts from pharmaceutical, aerosol, and respiratory care fields to support innovative research, build consensus, and advance the field.
She is the first author of the book "A Guide to Aerosol Delivery Devices for Respiratory Therapists, 2nd Edition." With over 3 million downloads worldwide, the book has been translated into Spanish, Chinese, Italian, Turkish, and Arabic.
Dr. Ari’s research impact is evident through her H-index of 31 and 3,369 citations. She consistently publishes in leading journals. Her work has been recognized with prestigious awards such as the Monaghan Award for Aerosol Technique Development (three-time recipient), the Presidential Award for Excellence in Scholarship, the Mitchell Baran Achievement Award for Clinical Excellence in Aerosol Therapy, and the H. Garza Achievement Award for Excellence in International Respiratory Care. She is an Associate Editor of the Canadian Journal for Respiratory Care, a Guest Editor for Pharmaceutics, and serves on the Editorial Board of the Journal of Aerosol Medicine.